Return to Faculty List


Maria Longo (Sorbera)

Associate Professor of Pharmacy Practice


Dr. Longo received her PharmD degree from Long Island University. She completed a Post Graduate Year (PGY)-1 Residency at the NY Harbor VA Healthcare system where she developed an interest in ambulatory care. This interest led her to complete a PGY-2 Ambulatory Care Residency at The Brooklyn Hospital Center. Before joining LIU Pharmacy, she practiced in academia for approximately two years. Dr. Longo is an Associate Professor of Pharmacy Practice with her practice at The Brooklyn Hospital Center where she also serves as the PGY-2 Ambulatory Care residency program director. She provides outpatient and inpatient HIV clinical services.  In addition, Dr. Longo serves as a preceptor at her practice site and is heavily involved with research in the pharmacy residency programs.  

Dr. Longo is board certified in ambulatory care (BCACP) and certified as an HIV pharmacist (AAHIVP). She is also certified to practice collaborative drug therapy management in New York.


HIV/AIDS, Hepatitis C, Primary Care, Pharmacist’s role in chronic disease state management.


  • Fischetti, B., Sorbera, M.,* Michael, R., Njeim, N. (2022) Evaluation of rates of virologic suppression in HIV-positive patients with varying numbers of comorbidities. AJHP. 79(2):72-77.

  • Sorbera, M.,* Fischetti, B., Khaimova, K., Niewinski, M., Wen, K. (2021) Evaluation of virologic suppression rates during the COVID-19 pandemic with outpatient interdisciplinary HIV care. J Am Coll Clin Pharm:1–5.

  • Cope, R.,* Fischetti, B., Kavangh, R., Lepa, T., Sorbera, M. (2019) Safety and Efficacy of Weight-Loss Pharmacotherapy in Persons Living with HIV: A Review of the Literature and Potential Drug-Drug Interactions with Antiretroviral Therapy. Pharmacotherapy. 39(12):1204-1215.

  • Sorbera, M.,* Mathew, C., Ramdeen, S. (2018) Implementation of a Hepatitis C. Collaborative Drug Therapy Management Service in an HIV Ambulatory Care Clinic. INNOVATIONS in pharmacy. 9(1):Article 6.

  • Sorbera, M.,* Joseph, T., DiGregorio, R. (2017) Elevated International Normalized Ratio in a Patient Taking Warfarin and Mauby: A Case Report. J Pharm Pract. 30(5):567-570.

  • Sorbera, MA., Friedman, ML., Cope, R.* (2017) New and Emerging Evidence on the Use of Second-Generation Direct Acting Antivirals for the Treatment of Hepatitis C Virus in Renal Impairment. J Pharm Pract. 30(3):359-365.

  • Del Bello, D.,* Cha, A., Sorbera, M., et al. (2015) Real-world Sustained Virologic Response Rates of Sofosbuvir-containing Regimens in Patients Coinfected with Hepatitis C and HIV. Clin Infect Dis. 62(12):1497-1504.

  • Sorbera, M., Chung, E., Ho, CW.,* Marzella, N. (2014) Ceftolozane/Tazobactam: A New Option in the Treatment of Complicated Gram-Negative Infections. Pharmacy and Therapeutics. 39(12):825, 828-832.